Literature DB >> 19323775

Equivocal colonic carcinogenicity of Aloe arborescens Miller var. natalensis berger at high-dose level in a Wistar Hannover rat 2-y study.

M Yokohira1, Y Matsuda, S Suzuki, K Hosokawa, K Yamakawa, N Hashimoto, K Saoo, K Nabae, Y Doi, T Kuno, K Imaida.   

Abstract

A 2-y carcinogenicity study of Aloe, Aloe arborescens Miller var. natalensis Berger, a food additive, was conducted for assessment of toxicity and carcinogenic potential in the diet at doses of 4% or 0.8% in groups of male and female Wistar Hannover rats. Both sexes receiving 4% showed diarrhea, with loss of body weight gain. The survival rate in the 4% female group was significantly increased compared with control females after 2 y. Hematological and biochemical examination showed increase of RBC, Hb, and Alb in the 4% males. The cause of these increases could conceivably have been dehydration through diarrhea. AST and Na were significantly decreased in the males receiving 4%, and Cl was significantly decreased in both 4% and 0.8% males. A/G was significantly increased in the 4% females, and Cl was significantly decreased (0.8%) in the female group. Histopathologically, both sexes receiving 4% showed severe sinus dilatation of ileocecal lymph nodes, and yellowish pigmentation of ileocecal lymph nodes and renal tubules. Adenomas or adenocarcinomas in the cecum, colon, and rectum were observed in 4% males but not in the 0.8% and control male groups. Similarly, in females, adenomas in the colon were also observed in the 4% but not 0.8% and control groups. In conclusion, Aloe, used as a food additive, exerted equivocal carcinogenic potential at 4% high-dose level on colon in the 2-y carcinogenicity study in rats. Aloe is not carcinogenic at nontoxic-dose levels and that carcinogenic potential in at 4% high-dose level on colon is probably due to irritation of the intestinal tract by diarrhea.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19323775     DOI: 10.1111/j.1750-3841.2009.01070.x

Source DB:  PubMed          Journal:  J Food Sci        ISSN: 0022-1147            Impact factor:   3.167


  8 in total

1.  Treatment-related changes after short-term exposure of SD rats to Aloe vera whole-leaf freeze-dried powder.

Authors:  Tao Chen; Li Wang; Chunyan Hu
Journal:  Int J Exp Pathol       Date:  2017-10       Impact factor: 1.925

2.  In vitro investigation of the mutagenic potential of Aloe vera extracts.

Authors:  Xiaoqing Guo; Suhui Zhang; Stacey L Dial; Mary D Boudreau; Qingsu Xia; Peter P Fu; Dan D Levy; Martha M Moore; Nan Mei
Journal:  Toxicol Res (Camb)       Date:  2014-08-11       Impact factor: 3.524

Review 3.  The dark side of miracle plant-Aloe vera: a review.

Authors:  Alka Jangra; Garima Sharma; Sonia Sihag; Vinod Chhokar
Journal:  Mol Biol Rep       Date:  2022-01-29       Impact factor: 2.742

4.  Clear evidence of carcinogenic activity by a whole-leaf extract of Aloe barbadensis miller (aloe vera) in F344/N rats.

Authors:  Mary D Boudreau; Paul W Mellick; Greg R Olson; Robert P Felton; Brett T Thorn; Frederick A Beland
Journal:  Toxicol Sci       Date:  2012-09-11       Impact factor: 4.849

5.  The effects of crude aqueous and alcohol extracts of Aloe vera on growth and abdominal viscera of suckling rats.

Authors:  Wabeya Beya; Bruce Davidson; Kennedy H Erlwanger
Journal:  Afr J Tradit Complement Altern Med       Date:  2012-07-01

Review 6.  Aloe vera Is Effective and Safe in Short-term Treatment of Irritable Bowel Syndrome: A Systematic Review and Meta-analysis.

Authors:  Seung Wook Hong; Jaeyoung Chun; Sunmin Park; Hyun Jung Lee; Jong Pil Im; Joo Sung Kim
Journal:  J Neurogastroenterol Motil       Date:  2018-10-01       Impact factor: 4.924

7.  Safety evaluation of Aloe vera soft capsule in acute, subacute toxicity and genotoxicity study.

Authors:  Jun Wu; Ying Zhang; Zhongming Lv; Ping Yu; Weiqing Shi
Journal:  PLoS One       Date:  2021-03-26       Impact factor: 3.240

8.  Therapeutic strategies targeting Wnt/β‑catenin signaling for colorectal cancer (Review).

Authors:  Yong Ji; Jian Lv; Di Sun; Yufeng Huang
Journal:  Int J Mol Med       Date:  2021-10-29       Impact factor: 4.101

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.